(Q39812281)

English

Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

based on heuristic

inferred from title

author name string

Kathleen R Sheridan

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Brian A Potoski

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Ryan K Shields

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Gerard J Nau

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

1 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1247-1251

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Visual outcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureus-associated acute endophthalmitis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

Endogenous endophthalmitis caused by methicillin-resistant Staphylococcus aureus (MRSA).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

Novel multiplex PCR assay for simultaneous identification of community-associated methicillin-resistant Staphylococcus aureus strains USA300 and USA400 and detection of mecA and Panton-Valentine leukocidin genes, with discrimination of Staphylococcu

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

In vivo pharmacodynamics of a new oxazolidinone (linezolid)

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.12.1247

21 January 2018

Identifiers

10.1592/PHCO.30.12.1247

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39812281&oldid=2090778366"